| Literature DB >> 24795546 |
Markus Wallwiener1, Philippe Robert Koninckx2, Andreas Hackethal3, Hans Brölmann4, Per Lundorff5, Michal Mara6, Arnaud Wattiez7, Rudy Leon De Wilde8.
Abstract
The present survey was conducted among gynaecological surgeons from several European countries to assess the actual knowledge and practice related to post-surgical adhesions and measures for reduction. From September 1, 2012 to February 6, 2013, gynaecological surgeons were invited to answer an 18-item online questionnaire accessible through the ESGE website. This questionnaire contained eight questions on care settings and surgical practice and ten questions on adhesion formation and adhesion reduction. Four hundred fourteen surgeons participated; 70.8 % agreed that adhesions are a source of major morbidity. About half of them declared that adhesions represented an important part of their daily medical and surgical work. About two thirds informed their patients about the risk of adhesion. Most cited causes of adhesions were abdominal infections and extensive tissue trauma, and endometriosis and myomectomy surgery. Fewer surgeons expected adhesion formation after laparoscopy (18.9 %) than after laparotomy (40.8 %); 60 % knew the surgical techniques recommended to reduce adhesions; only 44.3 % used adhesion-reduction agents on a regular basis. This survey gives a broad picture of adhesion awareness amongst European gynaecological surgeons, mainly from Germany and the UK. The participants had a good knowledge of factors causing adhesions. Knowledge of surgical techniques recommended and use of anti-adhesion agents developed to reduce adhesions need to be improved.Entities:
Keywords: Awareness; Gynaecological surgery; Post-surgical adhesions; Prevention
Year: 2013 PMID: 24795546 PMCID: PMC4003340 DOI: 10.1007/s10397-013-0824-2
Source DB: PubMed Journal: Gynecol Surg ISSN: 1613-2076
Fig. 1Distribution of survey respondents per type of hospitals
Mean and median numbers of interventions performed in 2010 in the gynaecology departments of the survey respondents (all participating countries)
| Intervention type | Mean ± SD | Median |
|---|---|---|
| Laparotomic | 1,213 ± 1,719 | 700 |
| Laparoscopic | 606 ± 710 | 380 |
| Vaginal | 389 ± 1,033 | 200 |
Fig. 2Number of laparoscopic interventions performed by each gynaecological surgeon
Summary of the number of surgical interventions performed in 2010 per hospital type: Germany and UK data
| Type of hospital | Country | Percentage of participants providing data on number of interventions % ( | Laparotomies mean number ± SD | Laparoscopies mean number ± SD | Vaginal route mean number ± SD |
|---|---|---|---|---|---|
| University hospital | Germany | 66.6 (24/36) | 1,236.7 ± 1,344.8 | 1,624.7 ± 1,730.0 | 998.7 ± 1,390.2 |
| UK | 87.5 (42/48) | 1,649.4 ± 1,086.6 | 827.6 ± 512.9 | 437.4 ± 333.2 | |
| Community hospital | Germany | 83.3 (25/30) | 409.5 ± 302.2 | 750.0 ± 589.7 | 298.0 ±264.9 |
| UK | 78.9 (15/19) | 1,518.2 ± 1,647.2 | 622.7 ± 562.7 | 265.9 ± 208.6 | |
| Private hospital | Germany | 78.5 (11/14) | 155.9 ±132.5 | 780.3 ± 819.8 | 383.1 ± 796.4 |
| UK | 87.5 (7/8) | 1,155.8 ± 1,214.1 | 1,192.7 ± 1,425.4 | 748.3 ± 1,163.7 | |
| Daycare hospital | Germany | 100 (2/2) | 0.0 ±0.0 | 1,650.0 ±1,202. | 1,200.0 ± 1,131.4 |
| UK | 0 | – | – | – |
Fig. 3Importance of patients with post-surgical adhesions in a gynaecologist’s daily work
Selected results of the present survey, presented after Hackethal et al [2]
| Entry | % of participants |
|---|---|
| Adhesions considered as a major source of morbidity | 70.8 |
| Adhesions considered as an important part of daily medical work | 50.4 |
| Adhesions considered as an important part of daily surgical work | 50.7 |
| Estimated incidence of adhesions post-laparotomy | 40.8 |
| Estimated incidence of adhesions post-laparoscopy | 18.9 |
| Patients informed of risk of adhesions during consenting | 64.3 |
| Regular use of anti-adhesion agents | 44.3 |
| Anti-adhesion agents considered as cost-effective | 77.5 |
| Anti-adhesion agents considered as too expensive | 71.6 |
| Anti-adhesion agents considered as insufficiently refunded | 75.8 |
| Consider themselves as well informed about adhesions | 60.0 |
| Source of adhesion knowledge | |
| Scientific publications | 85.6 |
| Personal experience | 82.6 |
| Discussions with colleagues | 75.8 |
| Continuous medical education | 84.7 |
| Consensus paper | 66.5 |
| ESGE conferences | 61.5 |
The type of surgery in benign conditions leading to intra-abdominal adhesions with the estimated likelihood on a scale from 0 (unlikely) to 4 (highly likely)
| Type of surgery | Median score ± SD of 5-point Likert rating scale | |
|---|---|---|
| Laparotomy | Laparoscopy | |
| Endometriosis surgery | 3.6 ± 0.6 | 2.8 ± 0.8 |
| Myomectomy | 3.4 ± 0.7 | 2.6 ± 0.9 |
| Adhesiolysis | 3.3 ± 0.7 | 2.5 ± 0.9 |
| Adnexal surgery | 2.9 ± 0.8 | 2.6 ± 0.8 |
| Hysterectomy | 3.1 ± 0.6 | 2.0 ± 0.7 |
| Ectopic pregnancy | 2.2 ± 0.8 | |
| Caesarean section | 2.5 ± 0.8 | |
Parameters influencing adhesion formation and the estimated likelihood on a scale from 0 (unlikely) to 4 (highly likely)
| Characteristic | Median score ± SD of five-point Likert rating scale |
|---|---|
| Infections within abdomen | 3.7 ± 0.7 |
| Extensive tissue trauma | 3.7 ± 0.6 |
| Postoperative infections | 3.6 ± 0.8 |
| Previous surgeries | 3.6 ± 0.6 |
| Foreign body incompatibility | 3.2 ± 1.0 |
| Quantity of sutures/staples/meshes | 3.2 ± 0.9 |
| Blood in abdomen | 3.2 ± 0.9 |
| Extensive coagulation | 3.2 ± 0.9 |
| Chronic inflammatory bowel diseases | 3.1 ± 1.0 |
| Affinity to reduce wound healing | 2.8 ± 0.9 |
Fig. 4Significance of some aspects of the peritoneal conditioning in the adhesions prevention (N = 247)
Summary of different adhesion prophylaxis products, knowledge of their existence, use, and importance rated on a scale from 0 (do not know this agent) to 2 (used it within the last 6 months)
| Adhesion prophylaxis products | Known (% of participants) | Used (% of participants) | Importance |
|---|---|---|---|
| Ringer lactate | 53.8 | 38.2 | 1.3 ± 0.6 |
| Adept/Icodextrin 4 % | 55.5 | 26.5 | 1.1 ± 0.7 |
| Interceed® | 56.3 | 23.9 | 1.0 ± 0.7 |
| Hyalobarrier Gel® | 56.3 | 19.3 | 0.9 ± 0.7 |
| Humidified/warm CO2 | 55.5 | 18.1 | 0.9 ± 0.7 |
| Intercoat® | 48.3 | 9.7 | 0.7 ± 0.6 |
| SprayShield® | 56.3 | 9.7 | 0.8 ± 0.6 |
| Seprafilm® | 63.8 | 4.6 | 0.6 ± 0.6 |
Fig. 5Use of adhesion-reduction agents within the six previous months, as a function of importance given to adhesions in daily surgical work